Skip to main content

Animations

MJFF Publications

3251 - 3260 of 9033 Results
Title
Year
  • Year
  • 2022
  • 2023
  • 2023
  • 2022
  • 2022
  • 2022
  • 2023
  • 2023
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Cumulative Effect of Head Injuries on Nonmotor Outcomes in Parkinson’s Disease
    Journal Name: The Journal of Neuropsychiatry and Clinical Neurosciences
    Publisher: American Psychiatric Association Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1176/appi.neuropsych.21100257
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Guanylyl cyclase C ameliorates visceral pain: an unsuspected link
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci166703
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?
    Journal Name: RNA
    Publisher: Cold Spring Harbor Laboratory
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1261/rna.079507.122
    Citation Count: 131
  • Summary Details
    OPEN
    Title: The Role of Transportation in the Enrollment of Elderly African Americans into Exercise and Memory Study: GEMS Study
    Journal Name: Journal of Racial and Ethnic Health Disparities
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s40615-022-01367-7
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer’s disease through polygenic risk and RNA sequencing
    Journal Name: Molecular Psychiatry
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41380-022-01926-8
    Citation Count: 17
  • Summary Details
    RESTRICTED
    Title: Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease
    Journal Name: Drugs
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s40265-022-01747-7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Patients’ Preferences for Adjunctive Parkinson’s Disease Treatments: A Discrete-Choice Experiment
    Journal Name: Patient Preference and Adherence
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.2147/ppa.s420051
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Temporal landscape of mitochondrial proteostasis governed by the UPR mt
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adh8228
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Clinical and Demographic Characteristics of Upper Limb Dystonia
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28223
    Citation Count: 13
  • Timing Is Everything: The T‐Cell Response to α‐Synuclein Is Maximal in Early Parkinson's
    2020
    Summary Details
    RESTRICTED
    Title: Timing Is Everything: The T‐Cell Response to α‐Synuclein Is Maximal in Early Parkinson's
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28122
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.